Inventor · disambiguated record
Alain Larocque
Also filed as: LAROCQUE ALAIN
4 granted patents·6 pending applications·11 citations·filing 2013–2025
70Inventor score
Top patents by PatentIndex Score
10 records- 0192US11780882B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2021·Granted Oct 10, 2023·3 cites·21 claims
- 0290US12269902B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2023·Granted Apr 8, 2025·1 cites·20 claims
- 0388US11034727B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2016·Granted Jun 15, 2021·6 cites·26 claims
- 0472US2025296957A1Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2025·Application pending·0 cites
- 0565US9687561B2Peptide-dendrimer conjugates and uses thereofANGIOCHEM INC·Filed 2013·Granted Jun 27, 2017·1 cites·19 claims
- 0655US2024156971A1Methods and sortilin binding conjugate compounds for targeting cancer stem cellsTRANSFERT PLUS SOC EN COMMANDITE·Filed 2022·Application pending·0 cites
- 0750US2023036041A1Sortilin binding conjugate compounds, compositions and uses thereof for treating cancerTHERATECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 0846US2022000971A1Methods and compounds for targeting sortilin receptors and inhibiting vasculogenic mimicryTRANSFERT PLUS SEC·Filed 2019·Application pending·0 cites
- 0946US2016367691A1Targeted enzyme compounds and uses thereofANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 1036US2020157151A1Peptide compounds, conjugate compounds and uses thereof for treating inflammatory diseasesTRANSFERT PLUS SEC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alain Larocque files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →